Plus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
Expanded pipeline with recently licensed targeted interventional radiotherapeutics platform Announced positive interim data from ReSPECT-GBM…
Expanded pipeline with recently licensed targeted interventional radiotherapeutics platform Announced positive interim data from ReSPECT-GBM…
– Significant progress made increasing global patient access to sotrovimab; approximately 1.7 million doses sold to…
– Patient enrollment continues in KOMET-001 Phase 1b study of ziftomenib (KO-539) in AML –…
Safety-critical multicore 6U solutions accelerate data-intensive sensor processing applications while lowering risk Mercury’s new BuiltSAFE…
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces an investigation on behalf of C3.ai,…
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (“CANbridge”, stock code 1228.HK), a leading China-based global…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a report analyzing the 1-year and lifetime transition of its ratings…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of C3.ai, Inc….
LADERA RANCH, CALIF.–(BUSINESS WIRE)–SmartStop Self Storage REIT, Inc. (“SmartStop” or the “Company”), a self-managed and…
NEW YORK & DUBLIN–(BUSINESS WIRE)–#KBRA–KBRA and KBRA Europe (collectively, KBRA) releases a brief report highlighting…
SAN DIEGO–(BUSINESS WIRE)–#Appointment–Taoglas®, a leading provider of advanced technology for a smarter world, today announced…
HOUSTON–(BUSINESS WIRE)–Oceaneering International, Inc. (“Oceaneering”) (NYSE:OII) today reported a net loss of $38.8 million, or…
COVINGTON, La.–(BUSINESS WIRE)–Globalstar, Inc. (NYSE American: GSAT) today announced operating and financial results for the…
Key 2021 and post period events: Appointment of Dr. Paul Stoffels1 as new CEO, effective…
Phase 2a study in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) enrollment closed; topline…
– BDSI Acquisition Expected to Close Late Q1 2022 – – 2022 Revenue Guidance of…
Four top-line data readouts expected in 2022 from ongoing oral AMT-101 Phase 2 trials, as…
FDA Approved TYRVAYA™ (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of…
Initiating Phase 1 dose escalation study of MGC018 in combination with lorigerlimab (formerly MGD019) in…